Axa’s MiMedx Group MDXG Stock Holding History

Axa’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-23,700	Closed	-$165K	–	1385
2018 Q1	$165K	Buy	+23,700	New	+$276K	﹤0.01%	1331
2017 Q4	–	Sell	-23,300	Closed	-$277K	–	1376
2017 Q3	$277K	Buy	+23,300	New	+$346K	﹤0.01%	1217

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Axa's MDXG Position: Q2 2018 in Review

Axa sold out of MiMedx Group (MDXG) in Q2 2018, closing a stake of 23,700 shares — an estimated $165K sold.

Axa first reported a position in MDXG in Q3 2017 and held it in 2 quarters. The position peaked at $277K in Q3 2017. 213 funds tracked by Wall St. Rank hold MDXG as of Q2 2018.

Axa reported no remaining MiMedx Group position as of Q2 2018 after selling out during the quarter.
Axa sold 23,700 MiMedx Group shares in Q2 2018, an estimated $165K.
Axa first reported a position in MiMedx Group in Q3 2017 and held it in 2 quarters.
Axa's MiMedx Group position peaked at $277K in Q3 2017.
213 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2018.

Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.